Insmed Incorporated
INSM
$70.20
-$0.87-1.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.17% | 22.13% | 21.94% | 22.54% | 24.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.17% | 22.13% | 21.94% | 22.54% | 24.39% |
| Cost of Revenue | 30.76% | 29.63% | 29.15% | 21.91% | 18.95% |
| Gross Profit | 16.00% | 20.08% | 20.01% | 22.72% | 25.97% |
| SG&A Expenses | 33.85% | 24.26% | 21.19% | 23.79% | 29.62% |
| Depreciation & Amortization | 0.00% | -0.02% | -0.02% | -0.02% | -0.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.64% | 9.92% | 5.14% | 25.81% | 36.30% |
| Operating Income | -15.51% | -4.81% | 1.76% | -27.39% | -42.42% |
| Income Before Tax | -21.83% | -19.24% | -15.18% | -36.51% | -55.58% |
| Income Tax Expenses | 45.09% | 104.46% | 96.62% | 79.68% | 84.74% |
| Earnings from Continuing Operations | -21.91% | -19.44% | -15.36% | -36.62% | -55.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.91% | -19.44% | -15.36% | -36.62% | -55.66% |
| EBIT | -15.51% | -4.81% | 1.76% | -27.39% | -42.42% |
| EBITDA | -15.64% | -4.83% | 1.97% | -27.50% | -42.87% |
| EPS Basic | -4.45% | -5.41% | -2.95% | -22.78% | -37.57% |
| Normalized Basic EPS | 3.09% | 8.30% | 10.77% | -14.32% | -26.69% |
| EPS Diluted | -4.49% | -5.45% | -2.89% | -22.69% | -37.26% |
| Normalized Diluted EPS | 3.09% | 8.30% | 10.77% | -14.32% | -26.69% |
| Average Basic Shares Outstanding | 16.79% | 13.14% | 12.04% | 12.62% | 14.15% |
| Average Diluted Shares Outstanding | 16.79% | 13.14% | 12.04% | 12.62% | 14.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |